In the present study, we employed a different approach using GSEA, identifying the TGFβ signaling pathway to be enriched by dasatinib-resistant pre-BCR+/E2A-PBX1+ ALL cells. This evidence concerns the gene TGFB1 and acute lymphoblastic leukemia.